Universe Pharmaceuticals fields shareholder questions ahead of Sept. 30 annual meeting

UPC•2026-09-01

Record date and share counts

The record date is Aug. 31, 2026. Universe Pharmaceuticals said 5,008,313 Class A shares and 16,077 Class B shares were outstanding. Class B carries 100 votes per share.

Annual meeting items and share consolidation proposal

Universe Pharmaceuticals outlined voting items for its Sept. 30, 2026 annual meeting, including director re-elections and a conditional 1-for-10 share consolidation.

Share consolidation triggers if the Nasdaq closing bid stays below USD 1 for three straight sessions within 12 months. Consolidation would take effect on the 25th trading day after the trigger, change the CUSIP, issue no fractional shares, and round up holdings.

Adoption of an amended and restated memorandum requires a 2/3 vote and depends entirely on consolidation approval.

Sources

Universe Pharmaceuticals fields shareholder questions ahead of Sept. 30 annual meeting

Sec

Universe Pharmaceuticals fields shareholder questions ahead of Sept. 30 annual meeting

Record date and share counts

Annual meeting items and share consolidation proposal

Related News

Three East Texas refineries maintain power as storm passes nearby, sources say

California Resources outlines potential CO2 pipeline network to link California emitters with TerraVault storage sites

TransUnion SVP, Chief Accounting Officer Jennifer A. Williams disposes of common shares worth $129,117.52

Sources

Universe Pharmaceuticals fields shareholder questions ahead of Sept. 30 annual meeting

Rent The Runway - Enters Third Amendment To Credit Agreement On Sept 1, 2026 - SEC Filing

Cornerstone Strategic Investment Fund director Peter Greer acquires $9,945 of common shares